Alignment Healthcare, Inc.
NASDAQ:ALHCMedical - Healthcare Plans
+$0.48 today
- Market cap
- $1.41B
- Beta
- 1.15
- P/E (TTM)
- 227.0
- EPS (TTM)
- $0.10
Volume 6.79M
Average 5.33M
ALHC Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Alignment Healthcare, Inc.NASDAQ: ALHC
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue grows, but more slowly than its trailing trend
Q1 FY2026 revenue of $1.24B rose 33.3% year over year, behind the +41.8% change in trailing-twelve-month revenue. Sequentially, it rose 22.0% from the prior quarter. Over 3 fiscal years it compounded at +40.2% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 10 analysts of $5.27B (+33.3%) for the fiscal year ending Dec 2026, a slowdown from the +46.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.24B+22.0% QoQ
- Last fiscal yearDec 2025
- $3.95B+46.1% YoY
- LTMMar 2026
- $4.26B+41.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +33.3% | +29.0% | -4.2 pp |
| 1 year | +46.1% | +33.3% | -12.7 pp |
| 3-year CAGR | +40.2% | +25.1% | -15.1 pp |
| 5-year CAGR | +25.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 3.95B USD
- Year-over-year change
- +46.1%
- 4-year CAGR
- +35.6%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.95B | +46.1% |
| FY2024 | 2024-12-31 | 2.7B | +48.3% |
| FY2023 | 2023-12-31 | 1.82B | +27.2% |
| FY2022 | 2022-12-31 | 1.43B | +22.8% |
| FY2021 | 2021-12-31 | 1.17B | — |
Revenue vs competitors
How ALHC compares with its peers on the latest reported figures
- ALHC's LTM Mar 2026 revenue of $4.26B is the lowest of the 7 companies compared; the peer median is $173.96B.
- Its year-over-year change of +41.8% is the 2nd highest of 7, against a peer median of +6.2%.
- Over three fiscal years its annual growth of +40.2% compares with a peer median of +11.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $449.66B | +3.3% | +11.4% | |
| LTM Sep 2026 | $201.83B | +3.6% | +8.3% | |
| LTM Jun 2026 | $193.73B | +8.7% | +10.5% | |
| LTM Sep 2026 | $154.19B | +22.0% | +11.7% | |
| LTM Sep 2026 | $43.63B | -2.1% | +12.4% | |
| LTM Jun 2026 | $15.32B | +42.8% | +41.6% | |
| LTM Mar 2026 | $4.26B | +41.8% | +40.2% | |
| Peer median (excluding ALHC) | $173.96B | +6.2% | +11.5% | |
Competitors are the stored peer set for ALHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 1.43B | 1.82B | 2.7B | 3.95B |
| Cost of Revenue | 1.04B | 1.25B | 1.62B | 2.41B | 3.46B |
| Gross Profit | 128.73M | 184.28M | 201.03M | 296.69M | 488.56M |
| Gross Margin | 11.0% | 12.8% | 11.0% | 11.0% | 12.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 290.99M | 295.65M | 307.43M | 371.37M | 0 |
| Operating Expenses | 306.8M | 312.92M | 328.85M | 398.25M | 473.81M |
| Depreciation & Amortization | 16.03M | 17.49M | 21.67M | 27.06M | 30.48M |
| EBITDA | (161.81M) | (113.53M) | (105.3M) | (77.44M) | 45.32M |
| EBITDA Margin | -13.9% | -7.9% | -5.8% | -2.9% | 1.1% |
| Operating Income | (178.07M) | (128.64M) | (127.82M) | (101.56M) | 14.75M |
| Operating Margin | -15.2% | -9.0% | -7.0% | -3.8% | 0.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 17.44M | 18.29M | 21.23M | 23.55M | 15.8M |
| Other Income / Expenses | (17.21M) | (20.66M) | (20.38M) | (26.5M) | (15.71M) |
| Income Before Tax | (195.29M) | (149.3M) | (148.2M) | (128.05M) | (958K) |
| Pre-Tax Margin | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
| Income Tax Expense | 0 | 339K | (22K) | 21K | 20K |
| Net Income | (195.29M) | (149.55M) | (148.02M) | (128.04M) | (724K) |
| Net Margin | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
| EPS (Basic) | (1.14) | (0.83) | (0.79) | (0.67) | (0.00) |
| EPS (Diluted) | (1.14) | (0.83) | (0.79) | (0.67) | (0.00) |
| Weighted Avg Shares | 171.96M | 181.21M | 186.21M | 190.79M | 198.01M |
| Weighted Avg Shares (Diluted) | 171.96M | 181.21M | 186.21M | 190.79M | 198.01M |
Alignment Healthcare, Inc.
NASDAQ:ALHC
Intrinsic Alpha fair value
Locked
Current Price
$6.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.